OCUL
OCULAR THERAPEUTIX, INC
+0.44 (+4.41%)10.31USD740K成交股數2.3B市值–本益比(近四季)43.5股價營收比+0.1%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 13.5M+0% | 10.8M+1% | 13.3M-14% | 14.5M-12% | 13.5M-9% | 10.7M-28% | 15.4M+2% | 16.4M+8% | 14.8M | 14.8M | 15.1M | 15.2M |
| 營業成本 | 2.0M | 1.3M | 1.6M | 1.8M | 1.9M | 1.3M | 1.6M | 1.5M | 1.3M | 1.4M | 1.4M | 1.3M |
| 毛利 | 11.5M-0% | 9.5M+0% | 11.7M-16% | 12.8M-14% | 11.5M-14% | 9.4M-30% | 13.9M+1% | 14.9M+8% | 13.4M | 13.4M | 13.7M | 13.9M |
| 毛利率 | 85.1% | 87.7% | 88.0% | 87.8% | 85.6% | 88.2% | 89.9% | 90.8% | 91.0% | 90.6% | 90.9% | 91.4% |
| 研發費用 | 54.1M | 66.2M | 50.8M | 52.4M | 51.1M | 42.9M | 37.1M | 28.9M | 20.7M | 16.2M | 15.0M | 15.1M |
| 銷售管理費用 | 22.2M | 20.0M | 17.7M | 16.0M | 14.3M | 16.3M | 12.2M | 19.7M | 14.1M | 8.0M | 8.6M | 8.2M |
| 營業利益 | −82.1M+21% | −93.3M+46% | −69.8M+52% | −68.7M+58% | −67.6M+114% | −63.9M+219% | −46.0M+139% | −43.6M+112% | −31.6M | −20.0M | −19.2M | −20.6M |
| 營業利益率 | -609.3% | -865.5% | -526.5% | -472.3% | -502.6% | -597.5% | -298.2% | -265.1% | -214.0% | -135.4% | -127.4% | -135.5% |
| 稅後淨利 | −78.8M+16% | −88.6M+38% | −64.7M+77% | −69.4M+59% | −67.8M+5% | −64.1M+119% | −36.5M+6972% | −43.8M+112% | −64.8M | −29.2M | −516K | −20.7M |
| 淨利率 | -584.5% | -821.6% | -488.0% | -477.3% | -503.9% | -598.7% | -236.6% | -266.3% | -438.9% | -197.4% | -3.4% | -136.2% |
| 稀釋 EPS | -0.35-10% | -0.40+5% | -0.27+23% | -0.38+46% | -0.39-20% | -0.38+217% | -0.22-12% | -0.260% | -0.49 | -0.12 | -0.25 | -0.26 |
| 稀釋股數 | 225M | 224M | 187M | 184M | 173M | 169M | 167M | 166M | 132M | 85.6M | 85.1M | 78.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 599M | 667M | 737M | 345M | 391M | 350M | 427M | 460M | 483M | 196M | 111M | 66.6M |
| 應收帳款 | 30.3M | 24.3M | 30.7M | 30.8M | 30.4M | 25.2M | 30.2M | 30.2M | 26.5M | 26.2M | 23.6M | 27.3M |
| 存貨 | 3.8M | 3.7M | 3.6M | 3.5M | 3.0M | 3.3M | 2.4M | 2.5M | 2.6M | 2.3M | 2.3M | 2.2M |
| 總資產 | 671M | 733M | 808M | 411M | 451M | 406M | 490M | 517M | 539M | 252M | 162M | 123M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 151M | 151M | 154M | 153M | 145M | 140M | 138M | 139M | 131M | 161M | 155M | 119M |
| 股東權益 | 520M | 582M | 654M | 258M | 306M | 266M | 352M | 378M | 408M | 91.1M | 7.9M | 3.1M |
| 負債比 | 22.5% | 20.6% | 19.0% | 37.2% | 32.2% | 34.5% | 28.2% | 27.0% | 24.3% | 63.8% | 95.2% | 97.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −66.0M+48% | – | – | – | −44.7M | – | – | −33.9M | – | – | – |
| 資本支出 | – | 4.7M | – | – | – | 1.9M | – | – | 255K | – | – | – |
| 自由現金流 | – | −70.7M+52% | – | – | – | −46.6M | – | – | −34.1M | – | – | – |
| 折舊攤銷 | – | 1.3M | – | – | – | 981K | – | – | 920K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -655.1% | – | – | – | -435.6% | – | – | -231.1% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 52.0M
| Single Reportable | 52.0M | 100.0% | -18.5% |
|---|
產品／服務2025 年度 · 52.0M
| 產品 | 51.8M | 99.8% | -18.3% |
|---|---|---|---|
| Collaboration Revenue | 128K | 0.2% | -51.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 52.0M | -18.5% | −266M | -511.9% | -1.42 | −217M |
| FY2024 | 63.7M | +9.0% | −194M | -303.7% | -1.22 | −136M |
| FY2023 | 58.4M | +13.5% | −80.7M | -138.1% | -1.02 | −76.3M |
| FY2022 | 51.5M | +18.3% | −71.0M | -138.0% | -0.97 | −63.3M |
| FY2021 | 43.5M | +150.1% | −6.6M | -15.1% | -0.98 | −66.7M |
| FY2020 | 17.4M | +311.7% | −156M | -894.3% | -2.56 | −54.4M |
| FY2019 | 4.2M | +112.4% | −86.4M | -2,043.3% | -1.91 | −79.8M |
| FY2018 | 2.0M | – | −60.0M | -3,014.0% | -1.57 | −51.1M |